ADMINISTRATION SITE HAEMATOMA

ADMINISTRATION SITE HAEMATOMA was reported 40 times

These drug classes are most commonly taken by patients reporting ADMINISTRATION SITE HAEMATOMA:

# Drug Count
0 Corticosteroid [EPC] 5
1 Nonsteroidal Anti-inflammatory Drug [EPC] 5
2 Tumor Necrosis Factor Blocker [EPC] 4
3 Proton Pump Inhibitor [EPC] 3
4 Aldosterone Antagonist [EPC] 2
5 Antirheumatic Agent [EPC] 2
6 B Lymphocyte Stimulator-specific Inhibitor [EPC] 2
7 Intestinal Lipase Inhibitor [EPC] 2
8 Loop Diuretic [EPC] 2
9 Osmotic Laxative [EPC] 2
10 Platelet Aggregation Inhibitor [EPC] 2
11 RANK Ligand Inhibitor [EPC] 2
12 Serotonin-3 Receptor Antagonist [EPC] 2
13 Adenosine Receptor Agonist [EPC] 1
14 Alkylating Drug [EPC] 1
15 Amide Local Anesthetic [EPC] 1
16 Angiotensin 2 Receptor Blocker [EPC] 1
17 Antiarrhythmic [EPC] 1
18 Benzodiazepine [EPC] 1
19 CTLA-4-directed Blocking Antibody [EPC] 1
20 Calcium Channel Blocker [EPC] 1
21 Catecholamine [EPC] 1
22 Central alpha-2 Adrenergic Agonist [EPC] 1
23 Dietary Cholesterol Absorption Inhibitor [EPC] 1
24 Dihydropyridine Calcium Channel Blocker [EPC] 1
25 Fluoroquinolone Antibacterial [EPC] 1
26 Histamine-2 Receptor Antagonist [EPC] 1
27 Interleukin-6 Receptor Antagonist [EPC] 1
28 Leukocyte Growth Factor [EPC] 1
29 Nitrate Vasodilator [EPC] 1
30 Nucleoside Metabolic Inhibitor [EPC] 1
31 Opioid Agonist [EPC] 1
32 P2Y12 Platelet Inhibitor [EPC] 1
33 Parenteral Iron Replacement [EPC] 1
34 Phosphodiesterase 5 Inhibitor [EPC] 1
35 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
36 Prostacycline Vasodilator [EPC] 1
37 Radiographic Contrast Agent [EPC] 1
38 Recombinant Human Growth Hormone [EPC] 1
39 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1
40 Somatostatin Analog [EPC] 1
41 Thiazide Diuretic [EPC] 1
42 Vitamin B12 [EPC] 1
43 Vitamin C [EPC] 1
44 Vitamin D [EPC] 1
45 alpha-Adrenergic Agonist [EPC] 1
46 beta-Adrenergic Agonist [EPC] 1